Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients

Clinical trial NCT00828503 · UNKNOWN

Trial details

NCT number: NCT00828503
Sponsor: Marcus Saemann
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Disease

Start date: 2008-12-01
Primary completion: 2013-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.